TECHi.com
Overview for MRK coming soon.
Methodology published · Market data, model notes, and corrections process are public · Data policy · Corrections policy
NYSE · Healthcare · Profile
Merck & Company, Inc. (MRK) stock profile and business model
What Merck & Company, Inc. does, how the business earns money, and how valuation, peers, ownership, and risk shape the TECHi profile.
Section freshness
Price Aug 19, 3:44 PM EDT · Statements Jun 29, 8:00 PM EDT
Investor profile snapshot
MRK live price, business model and key metrics
Start with the live market print, then use this profile to connect Merck & Company, Inc.'s operating model with revenue, margins, peer context, and investor risk.
RealtimeRealtime regular-session pricing
$152.39
▲ +$17.22(+12.74%)3:44 PM ET - vs previous closeiQuote as of Aug 19, 2026, 3:44 PM EDT
Realtime NYSE quote as of Aug 19, 2026, 3:44 PM EDT.
Market data source
Today87%
$144.90L Aug 19 '26$153.47H Aug 19 '26
52-week100%
$77.58$152.60
Long-term ranges5Y, 10Y, Since first printHide
5Y100%
$70.89L Sep 17 '21$151.80H Aug 19 '26
10Y100%
$50.41L Apr 3 '18$151.80H Aug 19 '26
Since first print100%
$19.13L Mar 9 '09$151.80H Aug 19 '26
Live price
$152.39
Live during market hours
Market cap
$376.10B
Equity scale
Analyst view
Buy
Target $137.73 (-9.62% implied)
Company · Profile
About Merck & Company, Inc. (MRK)
Sector, leadership, and how Merck & Company, Inc. earns its revenue.
Healthcare
Company · Profile
About Merck & Company, Inc. (MRK)
Sector, leadership, and how Merck & Company, Inc. earns its revenue.
Merck & Company, Inc.
NYSE · MRK · US
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Country
- US
- Founded
- 2014
- Exchange
- NYSE
Business identity
Merck & Company, Inc. company facts and operating footprint
Overview for MRK coming soon.
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Founded
- 2014
- Country
- US
- Exchange
- NYSE
Registration and filing identifiersShowHide
- Asset type
- Common Stock
- Fiscal year end
- December
- Latest quarter
- Jun 30, 2026
- CIK
- 0000310158
Key metrics
MRK valuation, revenue and margin profile
- Market cap
- $376.10B
- Equity scale
- Revenue TTM
- $66.57B
- Trailing twelve months
- Net margin
- 4.77%
- Profit after expenses
- Revenue growth
- 5.07%
- Latest YoY quarter
- Free cash flow
- $4.48B
- Reported in USD
Margin quality snapshot
Net margin4.77%
Competitors
MRK competitors and peer context
Risk heatmap
MRK business risks investors should monitor
Valuation sensitivity
High122.94x
A premium multiple leaves less room for execution misses or slower growth.
Balance-sheet flexibility
MonitorD/E 1.29 · CR 1.32
Debt load and near-term liquidity shape how much strategic patience the company has.
Growth durability
Monitor5.07%
Latest YoY revenue growth is the first check on whether the business model is still expanding.
Market sensitivity
MonitorBeta 0.21
Higher beta can amplify drawdowns when rates, earnings expectations, or sector appetite shift.
Regulatory and operating pressure
ElevatedHealthcare
Clinical, reimbursement, approval, and policy shifts can change revenue timing and product economics.
MRK ownership and registration profile
- Float shares
- 2.46B
- Insider ownership
- 0.06%
- Institutional ownership
- 82.76%
Size & scale
- Market cap
- $376.10B
- Enterprise value
- $423.15B
- Shares outstanding
- 2.47B
- Currency
- USD
Frequently asked
Common questions.
What does Merck & Company, Inc. do?
The MRK Profile page keeps the available company description, sector, industry, leadership, headquarters, workforce, and product context together.
Where does TECHi source the MRK profile?
Profile fields come from the unified company record and provider data; unavailable identity fields remain blank rather than inferred.